Melanoma Management

期刊简介：Skin cancer is on the rise. According to the World Health Organization, 132,000 melanoma skin cancers occur globally each year. While early-stage melanoma is usually relatively easy to treat, once disease spreads prognosis worsens considerably. Therefore, research into combating advanced-stage melanoma is a high priority. New and emerging therapies, such as monoclonal antibodies, B-RAF and KIT inhibitors, antiangiogenic agents and novel chemotherapy approaches hold promise for prolonging survival, but the search for a cure is ongoing. Melanoma Management publishes high-quality peer-reviewed articles on all aspects of melanoma, from prevention to diagnosis and from treatment of early-stage disease to late-stage melanoma and metastasis. The journal presents the latest research findings in melanoma research and treatment, together with authoritative reviews, cutting-edge editorials and perspectives that highlight hot topics and controversy in the field. Independent drug evaluations assess newly approved medications and their role in clinical practice. Key topics covered include: Risk factors, prevention and sun safety education Diagnosis, staging and grading Surgical excision of melanoma lesions Sentinel lymph node biopsy Biological therapies, including immunotherapy and vaccination Novel chemotherapy options Treatment of metastasis Prevention of recurrence Patient care and quality of life Melanoma Management delivers an accessible overview of current and future melanoma management options in a concise format that is ideal for the busy clinician. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including COPE, ICMJE and GPP3.

【译文】皮肤癌呈上升趋势。据世界卫生组织统计，全球每年发生 132,000 例黑色素瘤皮肤癌。虽然早期黑色素瘤通常相对容易治疗，但一旦疾病扩散，预后就会大大恶化。因此，对抗晚期黑色素瘤的研究是当务之急。单克隆抗体、B-RAF 和 KIT 抑制剂、抗血管生成药物和新型化疗方法等新兴疗法有望延长生存期，但治愈方法的探索仍在继续。黑色素瘤管理发表关于黑色素瘤各个方面的高质量同行评审文章，从预防到诊断，从早期疾病的治疗到晚期黑色素瘤和转移。该杂志介绍了黑色素瘤研究和治疗的最新研究成果，以及突出该领域热点话题和争议的权威评论、前沿社论和观点。独立药物评估评估新批准的药物及其在临床实践中的作用。涵盖的主要主题包括： 危险因素、预防和阳光安全教育 诊断、分期和分级 黑色素瘤病灶的手术切除 前哨淋巴结活检 生物疗法，包括免疫疗法和疫苗接种 新的化疗方案 转移治疗 预防复发 患者护理和生活质量 黑色素瘤管理以简洁的形式提供当前和未来黑色素瘤管理选项的概述，非常适合忙碌的临床医生。欢迎主动提出文章建议，作者必须完全遵守期刊的披露和利益冲突政策以及主要出版指南，包括 COPE、ICMJE 和 GPP3。